Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group

PHASE2TerminatedINTERVENTIONAL
Timeline

Start Date

June 30, 2003

Study Completion Date

February 28, 2005

Conditions
Hepatitis B
Interventions
DRUG

Clevudine

Trial Locations (7)

Unknown

Korea University Guro Hospital, Guro-dong

Seoul National University, Yeongeon-dong

Samsung Medical Center, Ilwon-dong

Yongdong Severance Hospital, Togok-tong

Asan Medical Center, P’ungnabi-dong

Ewha Womans University Hospital, Mokdong

St. Mary's Hospital, Youido

Sponsors
All Listed Sponsors
lead

Bukwang Pharmaceutical

INDUSTRY

NCT00313261 - Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo Group | Biotech Hunter | Biotech Hunter